Our @LDH™ formulation technology’s ability to intercalate acidic cannabinoids is a game-changer. This ensures consistent and stable formulations, enhancing shelf life, potency, and bioavailability of botanical extracts.
In the world of botanicals, most notably acidic cannabinoids (CBDA, THCA), stability is paramount. Mingowood Pharmacal spearheads innovation with its revolutionary @LDH™ formulation technology, providing a transformative solution for stabilizing a diverse array of botanicals.
Botanicals, especially acidic cannabinoids, are subject to rapid degradation from the time of purification from bulk botanical material. Environmental factors like light, heat, and oxygen degrade all the acidic cannabinoids, certainly CBDA and THCA, decreasing their potency, efficacy, and shelf life, thereby diminishing their therapeutic benefits.
Mingowood's @LDH™ formulation technology acts as a shield, intercalating botanicals in layered hydroxides to safeguard their active compounds. This innovative approach creates a stable matrix, shielding against external elements and ensuring extract integrity from production to consumption.
Mingowood Pharmacal's @LDH™ formulation technology empowers products with unmatched stability. Whether you are developing wellness products, pain relief formulations, or ethical pharmaceuticals, partner with Mingowood to unlock the full potential of stability with @LDH™.
Mingowood Pharmacal
Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.